🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Beijing

← All China trials

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

38
Recruiting now
65
Active studies
Starting soon Phase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
Excyte Biopharma Ltd · started 2026-09
📍 Beijing
NCT07695740 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
Genfleet Therapeutics (Shanghai) Inc. · started 2026-09
📍 Beijing · Guangzhou · Harbin · Zhengzhou · Wuhan · Shenyang
NCT07678593 on ClinicalTrials.gov ↗
Starting soon
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study
Uterine Fibroids (UF), Microwave Ablation, Ultrasound
Peking University Aerospace Center Hospital · started 2026-08-01
📍 Beijing
NCT07754877 on ClinicalTrials.gov ↗
Starting soon
AI-assisted Rare Disease Diagnosis
Rare Disorders, Rare Diseases
Peking Union Medical College Hospital · started 2026-08-01
📍 Beijing · Cangzhou · Changchun · Dongguan · Foshan · Guiyang
NCT07650799 on ClinicalTrials.gov ↗
Starting soon Phase 3
A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia
Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd. · started 2026-08
📍 Beijing
NCT07680829 on ClinicalTrials.gov ↗
Starting soon Phase 1
A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection
Respiratory Syncytial Virus (RSV)
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. · started 2026-07-15
📍 Beijing
NCT07694557 on ClinicalTrials.gov ↗
Starting soon
Stellate Ganglion Block and Prognosis of Neurological Function After Subarachnoid Hemorrhage
Aneurysmal Subarachnoid Hemorrhage, Stellate Ganglion Block, Neurological Prognosis
Beijing Tiantan Hospital · started 2026-06-15
📍 Beijing
NCT07652749 on ClinicalTrials.gov ↗
Starting soon
A Multicenter Registry-Based Study Across the Spectrum of Degenerative Cervical Myelopathy
Degenerative Cervical Myelopathy, Non-myelopathic Degenerative Cervical Cord Compression, Asymptomatic Degenerative Cervical Cord Compression, Cervical Spinal Cord Compression
Wangjing Hospital, China Academy of Chinese Medical Sciences · started 2026-06-01
📍 Beijing
NCT07641699 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. · started 2026-05-15
📍 Beijing
NCT07518147 on ClinicalTrials.gov ↗
Starting soon Phase 3
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
NSCLC (Advanced Non-small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2026-05-01
📍 Beijing
NCT07560358 on ClinicalTrials.gov ↗
Starting soon EARLY_Phase 1
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD), Progressive Multiple Sclerosis (PMS), Relapsed/Refractory Myasthenia Gravis(r/r MS)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2026-04-20
📍 Hefei · Beijing · Wuhan · Taiyuan
NCT07583030 on ClinicalTrials.gov ↗
Recruiting Phase 3
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
Breast Cancer, Breast Reconstruction, Radiation Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2026-03-27
📍 Beijing
NCT07084519 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Oesophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC · started 2026-03-27
📍 Beijing · Jinan
NCT07405151 on ClinicalTrials.gov ↗
Recruiting
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
Jiangsu Trulive Medical Co., Ltd · started 2026-03-18
📍 Beijing
NCT07691307 on ClinicalTrials.gov ↗
Recruiting Phase 1
Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects
Health Services Research
Beijing InnoCare Pharma Tech Co., Ltd. · started 2026-03-13
📍 Beijing
NCT07535099 on ClinicalTrials.gov ↗
Recruiting
Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct
Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct
Xuanwu Hospital, Beijing · started 2026-01-31
📍 Beijing
NCT07345702 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · started 2026-01-22
📍 Beijing · Fuzhou · Meizhou · Shanghai · Chengdu
NCT07269145 on ClinicalTrials.gov ↗
Recruiting Phase 3
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Multiple Sclerosis
Sanofi · started 2026-01-14
📍 Beijing · Chengdu · Jiazhuang
NCT07325292 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc. · started 2025-12-04
📍 Beijing
NCT07262567 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Bristol-Myers Squibb · started 2025-12-03
📍 Beijing · Guangzhou · Shenzhen · Handan · Zhengzhou · Changsha
NCT06979453 on ClinicalTrials.gov ↗
Recruiting Phase 2
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alexion Pharmaceuticals, Inc. · started 2025-11-26
📍 Baotou · Beijing · Guangzhou · Hangzhou · Nanchang · Shenzhen
NCT07160608 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Smoking
Eli Lilly and Company · started 2025-11-03
📍 Beijing · Chengdu · Chongqing · Hangzhou · Linhai · Ningbo
NCT07223840 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Janssen Research & Development, LLC · started 2025-10-01
📍 Beijing · Changzhou · Cheng Du Shi · Chongqing · Foshan · Fuzhou
NCT07196748 on ClinicalTrials.gov ↗
Recruiting Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb · started 2025-09-22
📍 Bengbu · Beijing · Chongqing · Fuzhou · Guangzhou · Shenzhen
NCT07116967 on ClinicalTrials.gov ↗
Active Phase 2
A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B
Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd. · started 2025-09-02
📍 Hefei · Beijing · Sichuan · Chongqing · Fuzhou · Guangzhou
NCT07135349 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Akeso · started 2025-08-14
📍 Beijing · Fuzhou · Shijiazhuang · Harbin · Shanghai · Tianjin
NCT07023315 on ClinicalTrials.gov ↗
Recruiting
Real World Evidence Study of SYN023 in Children Exposed to Rabies
Rabies Post-exposure Prophylaxis
Synermore Biologics (Suzhou) Co., Ltd. · started 2025-08-02
📍 Beijing · Shenzhen · Changsha · Hengyang · Nanchang
NCT07327307 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
Phase I/II Study of SCTB39G in Advanced Solid Tumours
Advanced Malignant Solid Tumor
Sinocelltech Ltd. · started 2025-07-28
📍 Beijing
NCT07077252 on ClinicalTrials.gov ↗
Recruiting Phase 2
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
Huashan Hospital · started 2025-06-18
📍 Beijing · Chengdu · Shanghai
NCT07026994 on ClinicalTrials.gov ↗
Recruiting
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
Medullary Thyroid Carcinoma
Luo Yaping · started 2025-05-10
📍 Beijing
NCT07138716 on ClinicalTrials.gov ↗
Recruiting Phase 3
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. · started 2025-04-30
📍 Beijing · Chongqing · Guangzhou · Shijiazhuang · Changsha · Xuzhou
NCT06937944 on ClinicalTrials.gov ↗
Active Phase 2
Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma
Lymphoma
Daihong Liu · started 2025-04-01
📍 Beijing
NCT07094477 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects
Healthy Participants
Chengdu Brilliant Pharmaceutical Co., Ltd. · started 2025-01-10
📍 Beijing
NCT06760455 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Heart Failure, Heart Failure With Reduced Ejection Fraction
Cytokinetics · started 2024-12-19
📍 Beijing · Lanzhou · Guangzhou · Shenzhen · Luoyang · Changsha
NCT06736574 on ClinicalTrials.gov ↗
Recruiting
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. · started 2024-12-15
📍 Beijing · Tianjin · Wuhan · Zhengzhou
NCT07028970 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Metastatic Non-small Cell Lung Cancer
AstraZeneca · started 2024-10-04
📍 Baoding · Beijing · Bengbu · Changchun · Changsha · Chengdu
NCT06417814 on ClinicalTrials.gov ↗
Active Phase 3
A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation
Leber Hereditary Optic Neuropathy (LHON)
Wuhan Neurophth Biotechnology Limited Company · started 2024-09-19
📍 Beijing
NCT07406854 on ClinicalTrials.gov ↗
Starting soon
Incisional Negative Pressure Therapy to Prevent Animal Induced Wound Infection
Injury Caused by Animal Bites, Wound Infection
Peking University First Hospital · started 2024-08-20
📍 Beijing
NCT06558942 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase I Study of LX22001 for Injection in Healthy Subjects
Healthy
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. · started 2024-08-05
📍 Beijing
NCT06561542 on ClinicalTrials.gov ↗
Active Phase 2
Iptacopan in Patients With ANCA Associated Vasculitis
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Novartis Pharmaceuticals · started 2024-08-05
📍 Shijiazhuang · Zhengzhou · Beijing
NCT06388941 on ClinicalTrials.gov ↗
Recruiting
Study on the Trans-Carotid Artery Occlusion Shunt System Combined With Introducer Sets
Carotid Artery Stenosis, Carotid Artery Diseases
Shenzhen Wecan Medical Technology Co.,Ltd · started 2024-07-01
📍 Beijing
NCT06959628 on ClinicalTrials.gov ↗
Recruiting
Resting Energy Expenditure and Substrate Consumption in Cardiac Arrest Patients Under Target Temperature Management
Targeted Temperature Management, Cardiac Arrest, Resting Energy Expenditure, Nutrition
Tang Ziren · started 2024-06-01
📍 Beijing
NCT06575101 on ClinicalTrials.gov ↗
By invitation
Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
Breast Carcinoma, BRCA Mutation, Adjuvant Drug Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · started 2024-05-06
📍 Beijing
NCT06405295 on ClinicalTrials.gov ↗
Starting soon Phase 1
A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma, B-cell
Sinocelltech Ltd. · started 2024-04
📍 Beijing · Zhengzhou · Tianjin
NCT06318884 on ClinicalTrials.gov ↗
Recruiting
Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy
Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing · started 2024-02-14
📍 Beijing
NCT06248333 on ClinicalTrials.gov ↗
Recruiting Phase 2
Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
Relapsed Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma
Navy General Hospital, Beijing · started 2023-10-30
📍 Beijing
NCT06190067 on ClinicalTrials.gov ↗
Starting soon Phase 2
Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients
Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous Non-Small Cell Lung Cancer, Metastatic Non-squamous Non Small Cell Lung Cancer
Peking University First Hospital · started 2023-10
📍 Beijing
NCT06028633 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. · started 2023-09-11
📍 Beijing
NCT06707753 on ClinicalTrials.gov ↗
Recruiting
Quality Control of Ultrasound Images During Early Pregnancy Via AI
Early Pregnancy
Chinese Academy of Sciences · started 2023-09-01
📍 Beijing · Changsha
NCT06002412 on ClinicalTrials.gov ↗
Active Phase 2
Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)
Non Small Cell Lung Cancer Metastatic
Peking Union Medical College Hospital · started 2023-02-01
📍 Beijing
NCT05599789 on ClinicalTrials.gov ↗
Recruiting
Thrombus Imaging and Treatment Analytics in Neurology
Thrombus, Brain, Thrombosis
Chinese PLA General Hospital · started 2022-12-15
📍 Beijing
NCT05663281 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
High-risk NMIBC
Shanghai Hengrui Pharmaceutical Co., Ltd. · started 2022-11-23
📍 Beijing
NCT05410730 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
Solid Tumor
Guangzhou Gloria Biosciences Co., Ltd. · started 2022-10-31
📍 Beijing
NCT05909436 on ClinicalTrials.gov ↗
Recruiting
APP-based Precise Management System of Chronic Intractable Pain
Pain, Chronic, Pain, Intractable
Beijing Tsinghua Chang Gung Hospital · started 2022-09-26
📍 Beijing
NCT05761392 on ClinicalTrials.gov ↗
Recruiting
A National Registry on Chinese Patients With Cystic Fibrosis
Pulmonary Function
Peking Union Medical College Hospital · started 2022-04-01
📍 Beijing
NCT05289245 on ClinicalTrials.gov ↗
By invitation Phase 3
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
UCB Biopharma SRL · started 2022-02-03
📍 Beijing · Changchun · Chengdu · Chongqing · Fuzhou · Guangzhou
NCT05076617 on ClinicalTrials.gov ↗
Active Phase 1
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)
Gastrointestinal Stromal Tumors
Taiho Pharmaceutical Co., Ltd. · started 2021-12-01
📍 Beijing · Shanghai
NCT05245968 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Myasthenia Gravis
Janssen Research & Development, LLC · started 2021-07-15
📍 Beijing · Changchun · Changsha · Chengdu · Fuzhou · Guangzhou
NCT04951622 on ClinicalTrials.gov ↗
Active Phase 1
Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies
Mature B-cell Malignancies
BeiGene · started 2021-07-05
📍 Beijing · Guangzhou · Shenzhen · Zhengzhou · Wuhan · Changsha
NCT04883957 on ClinicalTrials.gov ↗
Recruiting Phase 3
Different Immunosuppressive Treatment in iMN
Idiopathic Membranous Nephropathy
Peking Union Medical College Hospital · started 2021-04-14
📍 Beijing
NCT04745728 on ClinicalTrials.gov ↗
Active Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Solid Tumors
Hoffmann-La Roche · started 2021-01-18
📍 Beijing · Chengdu · Shanghai · Tianjin · Xi'an
NCT04589845 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Medullary Thyroid Cancer
Loxo Oncology, Inc. · started 2020-02-11
📍 Hefei · Beijing · Chongqing · Fuzhou · Lanzhou · Guangzhou
NCT04211337 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
Takayasu Arteritis (TAK)
AbbVie · started 2020-02-04
📍 Beijing · Guangzhou · Shenzhen · Shenyang · Shanghai
NCT04161898 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)
Follicular Lymphoma and Marginal Zone Lymphoma
Beijing Mabworks Biotech Co., Ltd. · started 2019-11-28
📍 Beijing
NCT04110301 on ClinicalTrials.gov ↗
Recruiting
A National Registry on Chinese Patients With Lymphangioleiomyomatosis
Pulmonary Function
Peking Union Medical College Hospital · started 2017-01-01
📍 Beijing
NCT03193892 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2
Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/city/beijing (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.